| Health / Medical Topics |
Miglustat
A synthetic, N-alkylated imino analogue of D-glucose. Miglustat competitively and reversibly binds to and inhibits the activity of UDP-glucose ceramide glucosyltransferase, which catalyzes the initial step in the synthesis of glycosphingolipids (GSL). This leads to a decrease in the production of glycosphingolipid, which has important roles in various cellular processes. Miglustat can be used in substrate reduction therapy in diseases in which the enzyme glucocerebrosidase, that is responsible for the breakdown of GSL, is deficient. (NCI Thesaurus)
YOU MAY ALSO LIKE
A desoxynojirimycin derivative and inhibitor of alpha-glucosidase with antihyperglycemic activity. Miglitol binds to and inhibits alpha-glucosidase, an enteric enzyme found in the…
A drug used to end early pregnancies. It is also being studied in the treatment of some types of cancer and other…
A drug used to end early pregnancies. It is also being studied in the treatment of some types of cancer and other…
A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. Mifamurtide activates…
Human MIF wild-type allele is located in the vicinity of 22q11.23 and is less than 1 kb in length. This allele, which…
This gene plays a role in cell-mediated immunity and macrophage function.
